Other languages EHAVE, Inc.

Equities

EHVVF

CA28238M2058

Market Closed - OTC Markets Other stock markets 11:30:10 2024-05-24 am EDT			5-day change	1st Jan Change
0.0015 ^USD	+50.00%		+50.00%	+400.00%

2023	Ei.Ventures, Inc. cancelled the acquisition of Mycotopia Therapies Inc. from EHAVE, Inc. (OTCPK:EHVV.F) and others in a reverse merger transaction.	CI
2022	FDA Grants EHAVE, Inc. Consent to Proceed with Its Clinical Study on Intravenous Ketamine Infusion for Major Depressive Disorder	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ei.Ventures, Inc. cancelled the acquisition of Mycotopia Therapies Inc. from EHAVE, Inc. (OTCPK:EHVV.F) and others in a reverse merger transaction.	23-02-15
FDA Grants EHAVE, Inc. Consent to Proceed with Its Clinical Study on Intravenous Ketamine Infusion for Major Depressive Disorder	22-12-15
EHAVE, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-05-27
EHAVE, Inc. Auditor Raises 'Going Concern' Doubt	22-05-26
EHAVE, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	22-05-23
Ehave Announces Mycotopia Therapies Reaches Definitive Agreement on Triangular Merger with Ei.Ventures to Form PSLY.com to List on NASDAQ	22-05-23
Ehave, Inc. Announces MetaHealthU Will Enter The Market With A Focus On HPPD	22-04-19
Ehave, Inc. Continues Expansion Of KetaDASH Mobile Psychedelic Service By Providing Licensed Psychotherapists And Registered Nurses	22-03-03
EHAVE, Inc. (OTCPK:EHVV.F) completed the acquisition of Rejuv IV Inc.	22-02-08
Ehave, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-05-28

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer